Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Women's Health therapeutics Market Research Reports

Titlepublishedprice

Minerva-35 -Drug Insights, 2017

By Delve Insight
"...... lso provides the Minerva-35 sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Minerva-35, patents information and exclusivity data, route of synthesis, co......"
01-Jan-2017$1000

Postmenopausal Vaginal Atrophy  - Epidemiology Forecast To 2023

By Delve Insight
"...... a of Postmenopausal Vaginal Atrophy prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Postm......"
01-Jan-2017$2750

Nexplanon -Drug Insights, 2017

By Delve Insight
"...... provides the Nexplanon sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Nexplanon, patents information and exclusivity data, route of synthesis, competi......"
01-Jan-2017$1000

Vaginal Atrophy (Atrophic Vaginitis)-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Vulval Atrophy-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Vulvovaginal Candidiasis-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Women Infertility-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Labor And Delivery-Pipeline Insights, 2017

By Delve Insight
"...... cal, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designa......"
01-Jan-2017$1250

Puregon -Drug Insights, 2017

By Delve Insight
"...... des the Puregon sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Puregon, patents information and exclusivity data, route of synthesis, competitive lands......"
01-Jan-2017$1000

Ovulatory Dysfunction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... ction Report is to understand the market and pipeline status of the drugs around the Ovulatory Dysfunction to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. T......"
01-Jan-2017$2000

Avail upto 50% Discount on below Publisher Reports.